ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      4,567.80
      (
      0.38%
      )
      US Tech 100
      15,532.00
      (
      -0.39%
      )
      Dow Jones
      35,950.89
      (
      1.47%
      )
      Brent Oil
      80.595
      (
      0.28%
      )
      Bitcoin
      38,103.24
      (
      1.03%
      )
      Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Acadia Pharmaceuticals Inc (ACAD)

      7. Acadia Pharmaceuticals Inc (ACAD) News

      ACAD Acadia Pharmaceuticals Inc

      22.87
      0.74 (3.34%)
      Nov 30 2023 - Closed
      Delayed by 15 minutes
      Company Name Stock Ticker Symbol Market Type
      Acadia Pharmaceuticals Inc ACAD NASDAQ Common Stock
        Price Change Change Percent Stock Price Last Traded
      Upgrade Icon
      0.74 3.34% 22.87 20:00:00
      Open Price Low Price High Price Close Price Prev Close
      22.40 22.03 22.49 22.28 22.13
      more quote information »

      Recent News

      Date Time Source Heading
      11/30/202309:05BWAcadia Pharmaceuticals Initiates Pivotal Phase 3 Study of..
      11/28/202317:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      11/27/202309:05BWAcadia Pharmaceuticals Initiates Phase 2 Clinical Trial of..
      11/21/202318:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      11/21/202318:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      11/21/202318:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      11/21/202317:11EDGAR2Form 8-K - Current report
      11/21/202317:00BWAcadia Pharmaceuticals Announces Change in Research and..
      11/14/202316:12BWAcadia Pharmaceuticals Reports Inducement Grants Under..
      11/02/202316:21EDGAR2Form 8-K - Current report
      11/02/202316:05BWAcadia Pharmaceuticals Reports Third Quarter 2023 Financial..
      10/31/202316:05BWAcadia Pharmaceuticals to Participate in the Guggenheim..
      10/23/202309:05BWAcadia Pharmaceuticals Announces the Rett Sibling..
      10/19/202316:05BWAcadia Pharmaceuticals to Announce Third Quarter Financial..
      10/18/202317:00BWAcadia Pharmaceuticals Reports Inducement Grants Under..
      10/16/202317:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      10/06/202322:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      10/06/202321:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      9/22/202318:23BWAcadia Pharmaceuticals Reports Inducement Grants Under..
      9/19/202318:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      9/19/202316:05BWAcadia Pharmaceuticals Appoints Albert Kildani as Senior..
      9/15/202313:06EDGAR2Form 144 - Report of proposed sale of securities
      8/30/202316:05BWAcadia Pharmaceuticals to Participate at Upcoming Investor..
      8/23/202319:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      8/21/202311:15EDGAR2Form 144 - Report of proposed sale of securities
      8/14/202316:05BWAcadia Pharmaceuticals Reports Inducement Grants Under..
      8/02/202316:23EDGAR2Form 8-K - Current report
      8/02/202316:05BWAcadia Pharmaceuticals Reports Second Quarter 2023 Financial..
      8/01/202319:30BWAcadia Pharmaceuticals Reports Inducement Grants Under..
      7/24/202316:05BWAcadia Pharmaceuticals Appoints Kevin R. Oliver, Ph.D., as..
      7/19/202316:04BWAcadia Pharmaceuticals to Announce Second Quarter Financial..
      7/18/202318:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      7/18/202316:01EDGAR2Form 8-K - Current report
      7/14/202311:33EDGAR2Form 144 - Report of proposed sale of securities
      7/14/202307:51IHMARKETNEWSFriday’s Wall Street Highlights: JPMorgan Chase, Coinbase,..
      7/13/202320:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      7/13/202316:05BWAcadia Pharmaceuticals Acquires Ex-North American Rights to..
      7/13/202310:42EDGAR2Form 144 - Report of proposed sale of securities
      6/26/202317:00BWAcadia Pharmaceuticals Reports Inducement Grants Under..
      6/13/202316:05BWAcadia Pharmaceuticals Announces Phase 3 Development..
      6/08/202311:10BWNature Medicine Publishes Results from Pivotal Phase 3..
      6/01/202309:04BWAcadia Pharmaceuticals to Present at the Jefferies Global..
      5/08/202316:05BWAcadia Pharmaceuticals Reports First Quarter 2023 Financial..
      5/05/202316:04BWAcadia Pharmaceuticals Reports Inducement Grants Under..
      5/02/202309:04BWAcadia Pharmaceuticals to Present at Upcoming Investor..
      4/25/202309:04BWAcadia Pharmaceuticals to Announce First Quarter Financial..
      4/20/202309:04BWAcadia Pharmaceuticals to Present DAYBUE™ (trofinetide)..
      4/17/202309:04BWAcadia Pharmaceuticals Announces DAYBUE™ (trofinetide) is..
      4/11/202309:04BWAcadia Pharmaceuticals to Present at the 22nd Annual Needham..
      3/10/202321:45BWAcadia Pharmaceuticals Announces U.S. FDA Approval of..

      Your Recent History

      NASDAQ
      ACAD
      Acadia Pharmaceuticals
      Delayed Upgrade Clock